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Abstract
Background: The TGF-beta family protein activin has numerous reported activities with some
uncertainty in the reproductive axis and development. The precise roles of activin in in vivo system
were investigated using a transient gain of function model.
Methods: To this end, an expression plasmid, pCMV-rAct, with the activin betaA cDNA fused to
the cytomegalovirus promoter, was introduced into muscle of the female adult mice by direct
injection.
Results: Activin betaA mRNA was detected in the muscle by RT-PCR and subsequent Southern
blot analysis. Activin betaA was also detected, and western blot analysis revealed a relatively high
level of serum activin with correspondingly increased FSH. In the pCMV-rAct-injected female mice,
estrus stage within the estrous cycle was extended. Moreover, increased numbers of corpora lutea
and a thickened granulosa cell layer with a small antrum in tertiary follicles within the ovary were
observed. When injected female mice were mated with males of proven fertility, a subset of
embryos died in utero, and most of those that survived exhibited increased body weight.
Conclusion: Taken together, our data reveal that activin betaA can directly influence the estrous
cycle, an integral part of the reproduction in female mice and activin betaA can also influence the
embryo development as an endocrine fashion.
Background
Activin and inhibin were first identified as gonadal pro-
tein hormones that regulate the synthesis and secretion of
follicle stimulating hormone (FSH) in the pituitary gland
which in turn controls the gonadal function [1,2]. They
are members of the transforming growth factor-β super-
family of proteins [3]. Activin and inhibin are generated
through the combinatorial assembly of an α subunit and
two highly related β subunits, βA or βB to generate inhibin
A (αβA), inhibin B (αβB), activin A (βAβA), activin B
(βBβB), and activin AB (βAβB). Recently, activin βC, βD, βE
chains [4-6], and partially characterized activin AC (βA:
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βC) and activin BC (βB: βC) proteins have been reported,
although they are not expressed in the gonad [7]. Outside
the gonad, activin βA was reported to be expressed in early
pre- and postimplantation mouse embryos [8-10], and to
be involved in the formation of mesoderm [11], and in
secondary body axis formation in chick [12], zebrafish
[13], and amphibians [14]. Activin βA is also expressed in
the pituitary, placenta, bone marrow, brain, and spinal
cord although precise functions of extragonadal activin
are unclear [15].
In the reproductive axis, it has been recognized that
activin potentially has an endocrine and paracrine (or
autocrine) functions. The endocrine function of activin
was inferred from the fact that correlation between high
activin and high FSH in the mid cycle and luteo-follicular
transition period was observed [16]. The paracrine func-
tion of activin was inferred from the fact that antibodies
to activin B suppressed FSH secretion from cultured rat
pituitary cells [17]. Another paracrine role of activin
related to the reproduction is controversially reported in
the ovary within which activin inhibited follicular devel-
opment [18] whereas activin induced proliferation of the
granulosa cells [19,20]. Relating with the pregnancy,
activin has been reported to have effects on embryonic
development. Activin A increased the rate of morula for-
mation and the velocity of embryonic cleavage in mice
[21]. And activin also influenced body axis formation in
chick [12], zebrafish [13], and amphibian [14] during
embryo development as explained above. Our compre-
hensive understanding of the activin function which is
mainly based on the in vitro experiment, however, is still
uncertain in the context of individual organism. Thus, we
need to reinvestigate the actual functions in the in vivo
system. Transgenic animal is a good model for this.
As to the actual functions of activin, previous studies have
attempted in the intact organism through gene disruption
or transgenic overexpression approaches. However, peri-
natal or early embryonic lethality is observed in these
cases, so further studies for the activin functions are lim-
ited in adult organ [22,23]. Recent conditional knockout
of activin βA which revealed that activin influenced ovar-
ian growth and differentiation have extended the studies
in specific organ of an early stage of adult mice [24]. These
approaches, however, essentially do not permit the role of
activin in the adult animal. In order to overcome this lim-
itation and to investigate the actual function of activin in
the adult, we adopted an alternative approach as
described in our previous report [25]. Briefly, we tran-
siently expressed activin, a secreted factor, in muscle
under the control of the cytomegalovirus (CMV) pro-
moter and assessed its impact on peripheral physiology at
specific stage of female mice. The expression of foreign
genes using CMV promoter is reported to persist for at
least 22 weeks [26] which is thought to be enough period
for hormone to exert its action. Our result revealed that
activin  βA colud directly influence the estrous cycle in
female mice and the embryo development as an endo-
crine fashion.
Methods
Animals and experimental design
ICR mice at 2 months of age were purchased from the
Daehan Animal Center and maintained under light under
14 h light, 10 h dark illumination at 23°C, with food and
water available ad libitum. Plasmid DNA was purified and
injected as described [25]. To measure activin βA mRNA
and activin protein, a single injection of 300 μg pCMV-
rAct in 50 μl of 10% sucrose in saline was performed at
10:00 A.M. and tissues were harvested 4 days after injec-
tion (Figs. 1B, 2A). For the detection of activin and FSH in
serum, a single injection of 300 μg pCMV-rAct in 50 μl of
10% sucrose in saline was performed at 10:00 A.M. on
diestrus II after confirmation of the two consecutive nor-
mal estrous cycles and serum was harvested 4 days later
that is the diestrus II of the next cycle which normally
reveals lower level of FSH in mice. Estrous cycle stages
were determined by daily examination of vaginal cytology
at 9:30 A.M. (Fig. 2B). For the reproductive studies, the
first injection of 300 μg pCMV-rAct was performed at
10:00 A.M. on diestrus II and the second followed 4 days
later. After the first injection of plasmid, estrous cycle
stages were determined at 9:30 A.M. until next fifth cycle
(Fig. 3). For the ovarian histology, female mice at diestrus
I of the third cycle after injection of plasmid were sacri-
ficed. For the testicular histology, the first injection was
done and followed the second 4 days later. Then the mice
were sacrificed 7 days later after the second (Fig. 4). For
the developmental studies, the first injection was per-
formed 1 day before mating, and the second 6 days after
pregnancy was confirmed. Control mice were injected
with the same amount of pcDNA3 vector (Figs. 5, 6). All
the experiments were performed at least four times if not
otherwise noted, and representative results are shown.
Construction of the pCMV-rAct DNA expression vector
For the pCMV-rAct (6.9 kb), a 1.5-kb rat activin cDNA
digested with EcoR I was cloned into the EcoR I site of a
vector pcDNA3 (Invitrogen, USA) which contains a CMV
early promoter and a bovine growth hormone polyade-
nylation site (Fig. 1A). The correct insertion of activin βA
cDNA was confirmed by digestion with Kpn I.
Reverse transcription-polymerase chain reaction (RT-
PCR) and Southern blot hybridization
RT-PCR and Southern blot hybridization were performed
as described [27]. Briefly, muscles were homogenized
with denaturing solution (4 M guanidinium thiocyanate,
25 mM sodium citrate (pH 7), 0.5% N-lauryl sarcosine,Reproductive Biology and Endocrinology 2008, 6:63 http://www.rbej.com/content/6/1/63
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and 0.1 M 2-mercaptoethanol). The homogenate was
phenol/chloroform extracted, and the RNA precipitated
and quantified with a U.V. 2000 spectrophotometer
(Pharmacia, USA). A260/A280 ranged from 1.8 to 2.0.
Ten micrograms of total RNA were used in duplicate. The
RNA was then treated with DNase I (5 U, Promega, USA)
at 37°C for 10 min in order to remove genomic and plas-
mid DNA, and reverse transcribed at 42°C with random
hexamer primers and AMV reverse transcriptase
(Promega, USA) in a 20 μl reaction. A mixture of oligonu-
cleotide primers (500 ng each), dNTP, and Taq DNA
polymerase (2.5 U) was added to each reaction, the total
volume was brought to 100 μl with 1× PCR buffer [10 mM
Tris (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, and 0.01% gel-
atin] and the sample was overlaid with light mineral oil.
Amplification was performed for 30 cycles using an
annealing temperature of 65°C on an Omn-E thermal
cycler (Hybaid Limited, UK). For the activin βA gene, the
primers were designed to generate a 397 bp fragment. The
5' primer was 5'CCACACGACTTTTGCTGCCAG3' and the
3' primer was 5'GGTGATGATCTCCGAGGTCTG3'. After
amplification, the samples were chloroform extracted,
dried, resuspended in 10 μl TE buffer (10 mM Tris, pH
8.0, 1 mM EDTA), and electrophoresed on a 1.2% agarose
gel. The gel was photographed after ethidium bromide
staining. The PCR products were then denatured with
sodium hydroxide and transferred to Nytran filters (0.45
μm, Schleicher & Schuell, Germany) under vacuum. They
were hybridized with dixogenein-labeled activin βA cDNA,
blotted with anti-dixogenein AP (1:1000) (Roche, Ger-
many), washed, and exposed to X-ray film after blotting
with CSPD (Roche, Germany).
Protein blot analysis
Tissues were removed, homogenized in 400 μl of protein
extraction buffer [0.1 M NaCl, 0.01 M Tris-Cl (pH 7.6), 1
mM EDTA (pH 8.0), 0.1% TritonX-100, 1 μg/ml apro-
tinin, and 100 ng/ml phenylmethylsulfonyl fluoride], and
centrifuged four times. The homogenates were mixed with
an equal volume of 2 × SDS-loading buffer [100 mM Tris-
Cl (pH6.8), 200 mM DTT, 4% SDS, 0.2% BPB, 20% glyc-
erol], placed in boiling water for 10 min, and centrifuged.
The supernatants were transferred to fresh tubes. Samples
of each extract containing 10 μg protein were heated at
70°C for 10 min, electrophoresed on a 12% acrylamide
gel and transferred onto Nytran filters in transfer buffer
(39 mM glycine, 48 mM Tris base, 0.037% SDS, 20%
methanol). The blots were incubated overnight in block-
ing solution (5% nonfat dried milk, 0.02% sodium azide,
0.02% Tween) with shaking at 4°C, followed by exposure
pCMV-rAct structure and activin expression Figure 1
pCMV-rAct structure and activin expression. (A) Diagram of the pCMV-rAct construct. Functional elements include the 
cytomegalovirus (CMV) promoter, the activin cDNA, and the human growth hormone (hGH) poly(A) signal. (B) RT-PCR and 
(C) Southern blot analysis were performed as described in methods. Marker of pGEM3Z/infI was loaded in lane 1. RNA from 
the pCMV-rAct-injected mice was loaded in lane 3 after treatment with DNase I, reverse transcriptase, and PCR. RNAs from 
control mice and from the pCMV-rAct-injected mice without reverse transcription were used as a normal (lane 2) and an 
internal control (lane 4), respectively. pCMV-rAct plasmid was used as a positive control (lane 5). RT: reverse transcription, 
pCMV-rAct: pCMV-rAct-injected mice. +: treated (or reacted), -: not treated (or not reacted).Reproductive Biology and Endocrinology 2008, 6:63 http://www.rbej.com/content/6/1/63
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to primary activin βA antibodies (1:400) (Serotec, UK)
overnight. They were washed in milk-TBS-Tween for 30
min and incubated with secondary anti-rabbit Ig horse-
radish peroxidase-linked whole donkey antibody
(1:100)(Amersham Pharmacia Biotech, USA) in azide-
free blocking solution [5% nonfat dried milk, 150 mM
NaCl, 50 mM Tris-Cl (pH 7.5)] for 2 h. The secondary
antibody-specific signal was detected with an ECL kit
(Amersham Pharmacia Biotech, USA). For serum meas-
urement of activin βA or FSH, one microliter of serum was
obtained, electrophoresed, and western blot analysis was
performed, using primary activin βA antibodies (Serotec,
UK) or primary FSH antibodies (1:750) (Serotec, UK).
Histology and statistical analysis
The gross appearance of embryos and excised tissues from
injected and control mice were examined and the tissues
immediately fixed in fresh 4% paraformaldehyde in PBS,
pH 7.4. Following overnight fixation, they were dehy-
drated in ethanol and embedded in paraffin, and seven-
micrometer sections were prepared with a microtome
(Leica RM2235, Switzerland). The sections were de-par-
affinized with xylene, dehydrated in absolute ethanol,
and rehydrated in water. Sections were stained with hema-
toxylin, counterstained with eosin, and observed under a
light microscope (Olympus IX70, Japan) or a steromicro-
scope (Leica ME Apo, Switzerland). For the statistical
analysis, Student's t test was used for single comparison at
α = 0.01. Statistics were performed no less than four inde-
pendent experiments.
Results
In initial studies, we tested whether intramuscular injec-
tion was an effective means of expressing activin βA in
adult mice. At the transcription level, we investigated the
expression of activin βA. After injection of the pCMV-rAct
DNA construct (Fig. 1A), we obtained an expected 397 bp
PCR product in mouse muscle using RT-PCR with activin
βA-specific primers, indicating that it came from activin βA
mRNA (Fig. 1B lane 3). Subsequently, we reconfirmed
that the amplified PCR product really came from activin
βA mRNA by Southern blot analysis with the labelled
activin βA cDNA (Fig. 1C lane 3). At the protein level,
western blot analysis revealed that mature activin βA pro-
tein (14 kDa) was synthesized specifically in muscle from
pCMV-rAct-injected mice (Fig. 2A). Activin was also
detected in the ovary, but not in the liver and control mus-
cle. The level of serum activin βA protein was substantially
elevated in the pCMV-rAct-injected mice (Fig. 2B left).
Thus, both activin βA mRNA and protein were successfully
expressed in muscle and secreted into the serum by this
approach.
Activin was initially described and named for its ability to
enhance FSH secretion in the female reproductive axis. To
investigate whether the ectopically expressed activin βA
influences serum FSH, we measured FSH (24 kDa) by
western blot analysis and found an increase in serum FSH
in the injected mice (Fig. 2B right). The induced activin βA
(14 kDa) in serum was also found high at this time which
corresponded to the increased FSH (Fig. 2B left). For the
detection of FSH in serum, a single injection of pCMV-
rAct was performed at 10:00 A.M. on diestrus II after con-
firmation of the two consecutive normal estrous cycles
and serum was harvested 4 days later that is the diestrus II
of the next cycle which normally reveals low level of FSH
in mice. To examine the consequences of this altered FSH
and activin levels, we examined the estrous cycle. The
result was that the estrous cycle was extended at the third
one after two injection of the plasmid (Fig. 3A). Within
the estrous cycle, estrus stage was mainly influenced. One
case is that estrus stage was extended up to 6 days and die-
strus II was extended up to 3 days (Fig. 3B). The seemingly
Activin and FSH Figure 2
Activin and FSH. Western blot analysis was performed as 
described in methods. (A) Proteins from control muscle, 
ovary, and liver were used as a normal sample, a positive 
control, and a negative control, respectively. (B) One micro-
liter of serum was obtained from the pCMV-rAct-injected 
mice, electrophoresed, and performed to western blot as 
described in methods. The western blot shown is represent-
ative of results obtained from three independent experi-
ments.Reproductive Biology and Endocrinology 2008, 6:63 http://www.rbej.com/content/6/1/63
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Change in the estrous cycle Figure 3
Change in the estrous cycle. (A) Each stage of the estrous cycle was identified by daily examination of vaginal cytology at 
9:30 A.M. at a 100 × magnification. The first injection was carried out after confirming at least two normal estrous cycles and 
the second injection followed 4 days later. Note that the third estrous cycle was extended in the pCMV-rAct-injected female. 
The number of mice sacrificed is seven in each group (n = 7). Asterisks denote values that are significantly different from the 
mean control value (Student's t-test, *, p < 0.01). Values shown are mean ± standard deviation. (B) A photograph of one exam-
ple. Of note is that extended estrus stage up to six days was observed. Control: vehicle-injected female mouse, pCMV-rAct: 
pCMV-rAct-injected female mouse. DI: diestrus I, DII(1): diestrus II day 1, DII(2): diestrus II day 2, P: proestrus, E: estrus, E(1–
6): estrus day 1–6.Reproductive Biology and Endocrinology 2008, 6:63 http://www.rbej.com/content/6/1/63
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Histology of the gonad Figure 4
Histology of the gonad. The ovaries (A) and testis (B) were prepared as described in methods and observed at 40 × (A; 
Above, B) and 120 × (A; Below) magnification. Of note is that follicle revealed a thickened granulosa cell layer with a small 
antrum and increased numbers of corpora lutea were observed in the pCMV-rAct-injected female mouse. Asterisks indicate 
antra in the follicles of control mice.Reproductive Biology and Endocrinology 2008, 6:63 http://www.rbej.com/content/6/1/63
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Embryos from the pCMV-rAct-injected mice Figure 5
Embryos from the pCMV-rAct-injected mice. (A) The two surgically isolated embryos at left were obtained at E15.5 
from a pCMV-rAct-injected female mouse, one of which was dead (pCMV-rAct 1) and the other of which was atypically large 
(pCMV-rAct 2). Tissues of the embryos were observed at 6× magnification under the stereomicroscope (Leica ME Apo). (B) 
The embryos were weighted at E15.5. The number of embryos from control and the pCMV-rAct-injected female mice is 48 (N 
= 48), and 100 (N = 100), respectively. Asterisks denote values that were significantly different from control mean values (Stu-
dent's t-test, *, p < 0.01)Reproductive Biology and Endocrinology 2008, 6:63 http://www.rbej.com/content/6/1/63
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normal epithelial cells were clearly observed during 6
days.
When we observed the ovary, the size was slightly
increased in the pCMV-rAct-injected mice. And the ovary
in the pCMV-rAct-injected mice revealed a less cavity
across the ovarian section compared to control which had
small and numerous cavities. Moreover, increased num-
bers of corpora lutea were observed in the pCMV-rAct-
injected mice, indirectly suggesting the increased ovula-
tion (Fig. 4A, Above). Within the ovaries, the later follicu-
lar stages, including tertiary follicles, had a thickened
granulosa cell layer with a small antrum. The oocytes
appeared normal regardless of the abundant granulosa
cells (Fig. 4A, Below). ActivinβA was expressed in the testis
(15), implying some role. In order to gain some insight
into the role of activin in male reproduction, we also
applied our approach to the male mice. However, in case
of male mice, any noticeable change in the histology was
obtained except a slight increase in the number of sem-
iniferous tubules of the testis in the pCMV-rAct-injected
mice (Fig. 4B). We are under further investigation.
Since activin βA belongs to the TGF-β superfamily whose
members are mainly involved in embryonic development
[22], the possible role of activin βA in embryonic develop-
ment was investigated. To do this, female mice were
injected with pCMV-rAct while pregnant. The resultant
offspring proved to be large; day E15.5 embryos were
larger than similar aged control embryos (Fig. 5A pCMV-
rAct2). Also offspring revealed a more accelerated devel-
opment since more advanced vertebrae were observed. In
addition, up to 10% of the embryos died (Fig. 5A). Histo-
logical analysis at embryological day 15.5 (E15.5)
revealed severe tissue degradation across the body in the
dying embryos (Fig. 5A pCMV-rAct1). Abortions were
often observed within the uterus of the pCMV-rAct-
injected pregnant mice. All the prematurely delivered
embryos died immediately after delivery (data not
shown). The mean body weight of the surviving embryos
was about 1.5 times heavier than that of controls (Fig.
5B). These heavier body weights were maintained until 3
weeks after birth, but converged to control values by 6
weeks after birth (Fig. 6).
Discussion
To further understand the detailed physiological function
of activin βA in mammalian reproduction and develop-
ment, we applied a "transient gain of function" mouse
model as described in our previous research [25], using
naked DNA injection as a gene transfer method. Direct
injection of DNA into mouse muscle led to the appear-
ance of activin βA mRNA and protein, and had a variety of
consequences, including changes in estrous cycle, ovarian
histology, embryo size, and survival. This approach pro-
vides a relatively simple means of examining the roles of
the activin βA subunit in adult females and in develop-
ment that could be extended to other endocrine genes.
Activin was first identified as gonadal protein to stimulate
FSH in the pituitary gland [1,2]. When we induced activin
βA through direct DNA injection, FSH in serum of pCMV-
rAct-injected female was increased, suggesting that activin
can act endocrine factor in addition to the already known
paracrine factor. The resultant FSH enhancement also sug-
gests change of the estrous cycle. When we examined the
estrous cycle by vaginal smear method, the expected
extended estrus stage was observed. In this case, it was pre-
sumed that increased FSH by ectopic activin expression
induced follicle development in the ovary and subse-
quently elevated estrogen influenced the uterine tissue,
resulting in extended estrus. This mechanism might be
different from that of inhibin – induced estrus extension
[28] in that an inhibin α-induced extension was occurred
without increase of FSH.
With respect to the role of activin in reproductive tissues
of the female mice, controversial results have been
reported. Activin inhibited follicular development [18]
whereas activin induced proliferation of the granulosa
cells with FSH [19,20]. Our results support the granulose
cell proliferation by activin overexpression. It remains,
Growth rates of offspring from the pCMV-rAct-injected mice Figure 6
Growth rates of offspring from the pCMV-rAct-
injected mice. Body weights of the offspring that were 
obtained from control and pCMV-rAct-injected mice are 
shown for the first 6 weeks after birth. The number of off-
spring used for control and pCMV-rAct-injected mice is 32 
(N = 32) and 42 (N = 42), respectively. Asterisks denote val-
ues that are significantly different from control mean values 
(Student's t-test at each point, *, p < 0.01). Values shown are 
means ± standard deviation.Reproductive Biology and Endocrinology 2008, 6:63 http://www.rbej.com/content/6/1/63
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however, unclear whether activin acts solely or in the pres-
ence of FSH since FSH levels were significantly increased
following activin βA  overexpression in pCMV-rAct-
injected mice (Fig. 2B). The increased numbers of corpora
lutea in pCMV-rAct-injected mice was also observed in
intraovarian activin βA knockout mice [24]. However the
inducing mechanism of corpus luteum seemed to be dif-
ferent in that our approach adopted the addition of
activin  βA whereas an intraovarian activin βA knockout
approach did the loss of activin βA. It was inferred that our
addition of activin βA induced more corpora lutea with
normal degeneracy whereas conditional deletion of
activin  βA induced normal corpora lutea with blocked
degeneracy, both resulting in net increased corpora lutea
in number.
In male mice, the reproductive system seemed not to be
influenced by the induced expression of activin βA. Male
fertility was not changed in pCMV-rAct-injected mice. In
contrast, male sterility was observed in transgenic mice
expressing activin βA  [23]. Although the FSH was
increased by the excess activin βA as it is in the female, the
actual amount of FSH might be not enough to influence
the testis, either because there is a lesser induction of
activin βA in male compared to female mice with unex-
plainable reason (under investigation) or because the sen-
sitivity to FSH between the ovary and the testis might be
different. Minor changes in the testis could be directly
influenced by activin βA since the binding site of the
activin was observed within the testis and testis cell
[29,30].
Gene disruption studies suggest an essential role of activin
βA in embryonic development [22]. Our results indicate
that overexpression of activin βA during development also
has deleterious effects. In our experiments, some embryos
from litters of the pCMV-rAct-injected female mice died
during development, and the remaining embryos were
observed to be larger than controls at birth. The increased
size of the surviving embryos might be explained by their
ability to more effectively compete for nutrients once a
subset of the embryos die. Alternatively, the increased size
of some embryos may limit the nutritional supply to oth-
ers, contributing to the premature lethality that is
observed. Collectively, these data indicate that activin βA
is essential during development, but it is important that
its levels be tightly regulated, and excessive amounts of
activin are toxic or lethal. Consistent with the essential
role of activin βA and tight regulation of activin βA expres-
sion, it was reported that both activin βA and activin βB are
needed for development although activin βA at least is
maintained over a minimum threshold level for normal
growth and survival [31].
The larger size of the surviving mice in our study stands in
contrast to the small-sized activin βA overexpressing trans-
genic mice observed at 3 weeks of age in another study
[32]. In this case, the cause of the decreased size was pre-
sumed to be a thicker tongue and therefore a reduced abil-
ity to suckle. Another phenotype reported in activin βA-
overexpressing mice [32], replacement of fatty tissue by
connective tissue and a thickening of the epidermis, were
not observed in pCMV-rAct-injected mice.
In addition to contributing new information on the con-
sequences of altered activin βA expression in the adult
female, these studies provide several important technical
advances as previously reported [25]. Briefly, our
approach is a very simple method and can be applied to
many different species and to multiple strains of mice. For
secreted proteins, our approach can be used effectively to
study the phenotypic consequences of protein overexpres-
sion without the time-consuming production of trans-
genic mice. Moreover, the certain function of the protein
in adult which was blocked by the deleterious effect dur-
ing growth period in the overexpressing transgenic animal
such as activin βA-transgenic animal can be overcome by
this transient expression method.
Conclusion
Our data revealed that activin betaA could directly influ-
ence the estrous cycle, an integral part of the reproduction
in female mice and activin betaA also could influence the
embryo development as an endocrine fashion. Moreover,
our approach was proved to be efficient for functional
analysis of the secreted proteins as a transient gain of func-
tion model.
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